Literature DB >> 31230944

Autoinhibition Mechanism of the Ubiquitin-Conjugating Enzyme UBE2S by Autoubiquitination.

Anna K L Liess1, Alena Kucerova2, Kristian Schweimer3, Lu Yu4, Theodoros I Roumeliotis4, Mathias Diebold5, Olexandr Dybkov6, Christoph Sotriffer5, Henning Urlaub7, Jyoti S Choudhary4, Jörg Mansfeld8, Sonja Lorenz9.   

Abstract

Ubiquitin-conjugating enzymes (E2s) govern key aspects of ubiquitin signaling. Emerging evidence suggests that the activities of E2s are modulated by posttranslational modifications; the structural underpinnings, however, are largely unclear. Here, we unravel the structural basis and mechanistic consequences of a conserved autoubiquitination event near the catalytic center of E2s, using the human anaphase-promoting complex/cyclosome-associated UBE2S as a model system. Crystal structures we determined of the catalytic ubiquitin carrier protein domain combined with MD simulations reveal that the active-site region is malleable, which permits an adjacent ubiquitin acceptor site, Lys+5, to be ubiquitinated intramolecularly. We demonstrate by NMR that the Lys+5-linked ubiquitin inhibits UBE2S by obstructing its reloading with ubiquitin. By immunoprecipitation, quantitative mass spectrometry, and siRNA-and-rescue experiments we show that Lys+5 ubiquitination of UBE2S decreases during mitotic exit but does not influence proteasomal turnover of this E2. These findings suggest that UBE2S activity underlies inherent regulation during the cell cycle.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  E2 enzyme; K11 chain; NMR; X-ray crystallography; cell cycle; enzyme mechanism; mass spectrometry; mitosis; molecular dynamics; ubiquitin

Mesh:

Substances:

Year:  2019        PMID: 31230944     DOI: 10.1016/j.str.2019.05.008

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  7 in total

1.  UBE2S Learns Self-Control.

Authors:  Tatyana Bodrug; Nicholas G Brown
Journal:  Structure       Date:  2019-08-06       Impact factor: 5.006

2.  A Pan-Cancer Analysis of UBE2S in Tumorigenesis, Prognosis, Pathway, Immune Infiltration and Evasion, and Therapy Response from an Immune-Oncology Perspective.

Authors:  Haili Bao; Yi Luo; Guoshan Ding; Zhiren Fu
Journal:  J Oncol       Date:  2022-05-07       Impact factor: 4.501

3.  Dimerization regulates the human APC/C-associated ubiquitin-conjugating enzyme UBE2S.

Authors:  Anna K L Liess; Alena Kucerova; Kristian Schweimer; Dörte Schlesinger; Olexandr Dybkov; Henning Urlaub; Jörg Mansfeld; Sonja Lorenz
Journal:  Sci Signal       Date:  2020-10-20       Impact factor: 9.517

4.  Structural basis for the hyperthermostability of an archaeal enzyme induced by succinimide formation.

Authors:  Aparna Vilas Dongre; Sudip Das; Asutosh Bellur; Sanjeev Kumar; Anusha Chandrashekarmath; Tarak Karmakar; Padmanabhan Balaram; Sundaram Balasubramanian; Hemalatha Balaram
Journal:  Biophys J       Date:  2021-07-22       Impact factor: 3.699

5.  O-GlcNAc-Modification of NSL3 at Thr755 Site Maintains the Holoenzyme Activity of MOF/NSL Histone Acetyltransfease Complex.

Authors:  Linhong Zhao; Min Li; Tao Wei; Chang Feng; Tingting Wu; Junaid Ali Shah; Hongsen Liu; Fei Wang; Yong Cai; Jingji Jin
Journal:  Int J Mol Sci       Date:  2019-12-25       Impact factor: 5.923

6.  Ubc1 turnover contributes to the spindle assembly checkpoint in Saccharomyces cerevisiae.

Authors:  Heather E Arsenault; Julie M Ghizzoni; Cassandra M Leech; Anne R Diers; Stephane Gesta; Vivek K Vishnudas; Niven R Narain; Rangaprasad Sarangarajan; Jennifer A Benanti
Journal:  G3 (Bethesda)       Date:  2021-12-08       Impact factor: 3.154

7.  Functional conservation and divergence of the helix-turn-helix motif of E2 ubiquitin-conjugating enzymes.

Authors:  Kaeli A Welsh; Derek L Bolhuis; Anneroos E Nederstigt; Joshua Boyer; Brenda R S Temple; Thomas Bonacci; Li Gu; Alban Ordureau; J Wade Harper; Joshua P Steimel; Qi Zhang; Michael J Emanuele; Joseph S Harrison; Nicholas G Brown
Journal:  EMBO J       Date:  2021-12-23       Impact factor: 14.012

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.